Combined deodorant dispensing container and cap
Latest Bristol-Myers Squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Method of purity determination by capillary electrophoresis
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
- Supramolecular filamentous assemblies for protein purification
Description
FIG. 1 is a front elevational view of a combined deodorant dispensing container and cap showing our new design;
FIG. 2 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front elevational view of a modified embodiment illustrated in FIG. 1; and,
FIG. 6 is a top plan view of the embodiment of FIG. 5.
Referenced Cited
Patent History
Patent number: D333977
Type: Grant
Filed: Nov 29, 1990
Date of Patent: Mar 16, 1993
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Thomas Gatrost (Randolph, NJ), Natalie Pyden (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Mitchell I. Siegel
Attorney: Morton S. Simon
Application Number: 7/620,589
Type: Grant
Filed: Nov 29, 1990
Date of Patent: Mar 16, 1993
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Thomas Gatrost (Randolph, NJ), Natalie Pyden (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Mitchell I. Siegel
Attorney: Morton S. Simon
Application Number: 7/620,589
Classifications
Current U.S. Class:
D/9337;
D/9529